SlideShare une entreprise Scribd logo
1  sur  28
Evidence-based policy making…what type 
of evidence do we need? 
Mark Petticrew 
Faculty of Public Health and Policy 
London School of Hygiene and Tropical Medicine 
Improving health worldwide 
www.lshtm.ac.uk
• We live in a world of evidence-based everything…and 
everyone wants to be (seen to be) “evidence-based”
Evidence-based cosmetics
The Logic Model:
• The term “evidence” in public health is problematic, 
by evidence we often mean “trials”, and we wring our 
hands about the “weak” public health evidence 
base... 
• “There isn’t very much evidence, and what there is, 
isn’t very good”
• The term “evidence” is problematic, by evidence we 
often mean “trials”, and other sorts of evaluations of 
policies, and we have often wrung our hands about the 
“weak” public health evidence base... 
• “There isn’t very much evidence, and what there is, 
isn’t very good” 
• So we need to increase the “flow” of evaluations of the 
health effects of interventions (particularly those 
outside the health sector)
The inverse evidence law 
• The strongest evidence we have is often about risk factor 
modification, and we have more, “weaker” evidence about 
many of the wider social economic and environmental 
determinants of health (including policies) 
• E.g. The evidence on modal shift in transport - how to get 
people to walk and cycle more...
Types of intervention 
• “Health promotion” activities (Education campaigns; free 
bikes) 
• Engineering measures (Bicycle infrastructure; traffic 
restraint) 
• Financial incentives (voucher/fine to leave car at home) 
• Providing alternative services (e.g. A new railway station) 
• Complex urban transport policies
Study designs used to evaluate interventions to 
bring about modal shift (Ogilvie et al., 2007) 
N (studies) 
Randomised controlled trial (individual-level) 3 
Panel survey 13 
Repeated cross-sectional survey (community-level) 17 
Retrospective or after-only survey 11 
Case study /uncertain (city-level) 20
• Does “No trial”=“no evidence”?
Three public health interventions for 
which there is “no good evidence” 
• There have been 5 RCTs of the health effects of social 
housing investment. They don’t show major significant 
effects on health. 
• Is social housing “ineffective”, and so should be 
withdrawn? 
• (– I don’t think so)
Two more interventions for which there 
is no trial evidence (but which surely 
‘work’) 
• Zebra crossings: there are no trials, but there is 
direct experiential evidence, and excellent 
theory (“common sense”) that if you walk 
directly into the traffic you will be knocked 
down...there is no “equipoise” 
• Gritting pavements. Not worth asking for 
“perfect evidence”? However, if the question is 
about the comparative effectiveness (different 
“doses” of gritting, or salting vs gritting, or CBA 
of gritting vs public warnings) then this may be 
worth evaluating (though may not be ethical)
Source: theweekendinparis.com
The myth of the single 
“killer” study 
• In public health there is rarely one single, killer study which 
tells us definitively what to do (or stop doing) 
• Good evidence-informed decisions draw on the wider range of 
prior evidence (including observational evidence), theory as 
well as what is know about causal mechanisms; along with 
judgements about plausibility of effects across a range of 
outcomes 
• “Best available evidence” may often be good enough 
• …particularly given the need to act according to the 
precautionary principle
The need for replication 
• “Too many social scientists expect single experiments to settle 
issues once and for all. This may be a mistaken generalization 
from the history of great crucial experiments in physics and 
chemistry. In actuality the significant experiments in the physical 
sciences are replicated thousands of times, not only in deliberate 
replication efforts, but also as inevitable incidentals in successive 
experimentation and in utilizations of those many measurement 
devices (such as the galvanometer) that in their own operation 
embody the principles of classic experiments. 
(Campbell, Reforms as Experiments, 
1969).
• Because we social scientists have less ability to achieve 
“experimental isolation”, because we have good reason to 
expect our treatment effects to interact significantly with a 
wide variety of social factors, many of which we have not yet 
mapped, we have much greater needs for replication 
experiments than do the physical sciences….
• “Policy outcomes can be monitored with triangulated methods 
(accumulation of evidence from a variety of sources to gain 
insight, often combining quantitative and qualitative data)”* 
*Brownson, Chriqui & Stamakis (2009)
All those problems...where are 
the answers? 
• The answers do not lie simply in more epidemiology, or more 
research 
• But also in understanding the political and other cultures 
within which evidence is produced, valued, used, misused, or 
not used at all (in different sectors) 
• And a greater focus on the decisions that are taken: 
• “What type and strength of evidence (if any) is needed to 
support the decision that needs to be taken”
• Q: Is, as SV said yesterday, « the best the enemy of the good » in 
the case of public health evidence? (A: Yes) 
• We need robust RCTs where these are possible 
• For addressing the most complex influences on health, we need to 
also rely on complex sets of epidemiological evidence, including 
modelling studies, knowledge about causes and mechanisms 
• We need to be wary of over-emphasising the problems with public 
health evidence – it ignores the contribution of different types of 
evidence to decisionmaking 
• A cautionary tale about « methodological purism »:
The 7 CEO’s of Big Tobacco 
• Testified in turn to Senator Waxman’s hearings (1980-1994): “I believe that 
tobacco is not addictive” 
• The tobacco industry developed a range of sophisticated epidemiological 
and methodological arguments to undermine the public health evidence 
base on the harms of tobacco 
• Their “multifactorial causes” argument was developed to argue that 
epidemiological studies are hopelessly confounded; nothing can be 
“proved”:
“Stressed-out” smokers 
• “While some scientists have associated cigarette smoking with heart 
disease, it is certainly clear that a number of other factors including 
life-style, blood pressure, biochemistry, genetics and in particular, 
stress, may also be involved” 
• ‘‘These diseases are also statistically associated with many other 
variables, such as diet, lifestyle, heredity and stress. . . . But the 
existence of a statistical association does not mean that smoking 
causes these diseases.’’ (BAT statement to the Irish Joint Committee 
on Health and Children in 1998)* 
*Am J PH Paper on tobacco industry funding of stress: 
http://researchonline.lshtm.ac.uk/3743/
http://legacy.library.ucsf.edu/tid/rgy93f00
• Ulucanlar et al. (2014)
• First, published studies were repeatedly misquoted, distorting the 
main messages. 
• Second, ‘mimicked scientific critique’ was used to undermine 
• evidence; this form of critique insisted on methodological 
perfection, rejected methodological pluralism, adopted a litigation 
(not scientific) model*, and was not rigorous. 
• Third, TTCs engaged in ‘evidential landscaping’, promoting a parallel 
evidence base to deflect attention from SP and excluding company-held 
evidence relevant to SP. 
*Examining and discounting studies piece by piece
Example of evidential 
landscaping 
• ‘… the real drivers of smoking initiation include factors such as 
parental influences, risk preferences, peer influences, socioeconomic 
factors, access and price’
• Our natural scientific concern with rigour and internal validity 
needs to be balanced with the need to integrate a wide range 
of evidence to feed into policy and other decisions 
• We need to be aware of how others are interpreting and using 
the concept of evidence 
• Developing better public health evidence, is an incremental 
process
No, that last slide was too 
pessimistic… 
• A more positive message: 
• We have public health methods are as robust as those used in the 
physical sciences – the exact same methods in many cases 
• RISP methods are reliable, widely accepted, tried and tested 
(centuries old!) and appropriate for investigating and estimating the 
effects of policies on health 
• We need to take every opportunity to reinforce this message

Contenu connexe

En vedette

En vedette (16)

Colloque RI 2014 : Intervention de David W. BAKER, MD, MPH (Feinberg School o...
Colloque RI 2014 : Intervention de David W. BAKER, MD, MPH (Feinberg School o...Colloque RI 2014 : Intervention de David W. BAKER, MD, MPH (Feinberg School o...
Colloque RI 2014 : Intervention de David W. BAKER, MD, MPH (Feinberg School o...
 
Prédisposition et susceptibilité aux cancer de l'enfant - Thierry Frébourg
Prédisposition et susceptibilité aux cancer de l'enfant - Thierry FrébourgPrédisposition et susceptibilité aux cancer de l'enfant - Thierry Frébourg
Prédisposition et susceptibilité aux cancer de l'enfant - Thierry Frébourg
 
Colloque RI 2014 : Intervention de Sarah VIEHBECK (Institut de la santé publi...
Colloque RI 2014 : Intervention de Sarah VIEHBECK (Institut de la santé publi...Colloque RI 2014 : Intervention de Sarah VIEHBECK (Institut de la santé publi...
Colloque RI 2014 : Intervention de Sarah VIEHBECK (Institut de la santé publi...
 
Leucémies Aigües Lymphoblastiques de l'enfant, de l'adolescent et du jeune ad...
Leucémies Aigües Lymphoblastiques de l'enfant, de l'adolescent et du jeune ad...Leucémies Aigües Lymphoblastiques de l'enfant, de l'adolescent et du jeune ad...
Leucémies Aigües Lymphoblastiques de l'enfant, de l'adolescent et du jeune ad...
 
Modèles animaux et organoïdes - Françoise Rédini
Modèles animaux et organoïdes - Françoise RédiniModèles animaux et organoïdes - Françoise Rédini
Modèles animaux et organoïdes - Françoise Rédini
 
Présentation du PAIR pédiatrie - André Baruchel
Présentation du PAIR pédiatrie - André BaruchelPrésentation du PAIR pédiatrie - André Baruchel
Présentation du PAIR pédiatrie - André Baruchel
 
Génome, épigénome, signalisation - Olivier Bernard
Génome, épigénome, signalisation - Olivier BernardGénome, épigénome, signalisation - Olivier Bernard
Génome, épigénome, signalisation - Olivier Bernard
 
Sciences humaines et sociales - Perrine Marec-Bérard
Sciences humaines et sociales - Perrine Marec-BérardSciences humaines et sociales - Perrine Marec-Bérard
Sciences humaines et sociales - Perrine Marec-Bérard
 
Colloque RI 2014 : Intervention de Sylvie DOLBEAULT, MD, MPH (Institut Curie,...
Colloque RI 2014 : Intervention de Sylvie DOLBEAULT, MD, MPH (Institut Curie,...Colloque RI 2014 : Intervention de Sylvie DOLBEAULT, MD, MPH (Institut Curie,...
Colloque RI 2014 : Intervention de Sylvie DOLBEAULT, MD, MPH (Institut Curie,...
 
Prédisposition et susceptibilité aux cancer de l'enfant - Thierry Frébourg
Prédisposition et susceptibilité aux cancer de l'enfant - Thierry FrébourgPrédisposition et susceptibilité aux cancer de l'enfant - Thierry Frébourg
Prédisposition et susceptibilité aux cancer de l'enfant - Thierry Frébourg
 
Colloque RI 2014 : Intervention de O.J. SAHLER, MD (Golisano Children’s Hospi...
Colloque RI 2014 : Intervention de O.J. SAHLER, MD (Golisano Children’s Hospi...Colloque RI 2014 : Intervention de O.J. SAHLER, MD (Golisano Children’s Hospi...
Colloque RI 2014 : Intervention de O.J. SAHLER, MD (Golisano Children’s Hospi...
 
Radiothérapie - David Azria
Radiothérapie - David AzriaRadiothérapie - David Azria
Radiothérapie - David Azria
 
Essais de phase précoce - Gilles Vassal
Essais de phase précoce - Gilles VassalEssais de phase précoce - Gilles Vassal
Essais de phase précoce - Gilles Vassal
 
Interopérabilité – Bases de données - Jacqueline Clavel
Interopérabilité – Bases de données - Jacqueline ClavelInteropérabilité – Bases de données - Jacqueline Clavel
Interopérabilité – Bases de données - Jacqueline Clavel
 
Immunothérapie - Bernard Nadel
Immunothérapie - Bernard NadelImmunothérapie - Bernard Nadel
Immunothérapie - Bernard Nadel
 
Immunothérapie des cancers, nouveaux concepts - Aurélien Marabelle
Immunothérapie des cancers, nouveaux concepts - Aurélien MarabelleImmunothérapie des cancers, nouveaux concepts - Aurélien Marabelle
Immunothérapie des cancers, nouveaux concepts - Aurélien Marabelle
 

Similaire à Colloque RI 2014 : Intervention de Mark PETTICREW (London School of Hygiene and Tropical Medicine)

INTRODUCTION LECTURE_RESEARCH DESIGN AND METHODOLOGY.pptx
INTRODUCTION LECTURE_RESEARCH DESIGN AND METHODOLOGY.pptxINTRODUCTION LECTURE_RESEARCH DESIGN AND METHODOLOGY.pptx
INTRODUCTION LECTURE_RESEARCH DESIGN AND METHODOLOGY.pptx
AkwasiOwusu6
 
Ethical Considerations in Public Health
Ethical Considerations in Public HealthEthical Considerations in Public Health
Ethical Considerations in Public Health
Dr Ghaiath Hussein
 
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfCCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
MyThaoAiDoan
 
Bi ostat for pharmacy.ppt2
Bi ostat for pharmacy.ppt2Bi ostat for pharmacy.ppt2
Bi ostat for pharmacy.ppt2
yonas kebede
 

Similaire à Colloque RI 2014 : Intervention de Mark PETTICREW (London School of Hygiene and Tropical Medicine) (20)

INTRODUCTION LECTURE_RESEARCH DESIGN AND METHODOLOGY.pptx
INTRODUCTION LECTURE_RESEARCH DESIGN AND METHODOLOGY.pptxINTRODUCTION LECTURE_RESEARCH DESIGN AND METHODOLOGY.pptx
INTRODUCTION LECTURE_RESEARCH DESIGN AND METHODOLOGY.pptx
 
PRECAUTIONARY_PRINCIPLE_Policy_Responses_to_En (1).ppt
PRECAUTIONARY_PRINCIPLE_Policy_Responses_to_En (1).pptPRECAUTIONARY_PRINCIPLE_Policy_Responses_to_En (1).ppt
PRECAUTIONARY_PRINCIPLE_Policy_Responses_to_En (1).ppt
 
PRECAUTIONARY_PRINCIPLE_Policy_Responses_to_En.ppt
PRECAUTIONARY_PRINCIPLE_Policy_Responses_to_En.pptPRECAUTIONARY_PRINCIPLE_Policy_Responses_to_En.ppt
PRECAUTIONARY_PRINCIPLE_Policy_Responses_to_En.ppt
 
Research Fundamentals for Activists
Research Fundamentals for ActivistsResearch Fundamentals for Activists
Research Fundamentals for Activists
 
Innovative research approaches to improve evidence in global health
Innovative research approaches to improve evidence in global healthInnovative research approaches to improve evidence in global health
Innovative research approaches to improve evidence in global health
 
Ethical Considerations in Public Health
Ethical Considerations in Public HealthEthical Considerations in Public Health
Ethical Considerations in Public Health
 
Arvo egypt researching a bioethical question
Arvo egypt researching a bioethical questionArvo egypt researching a bioethical question
Arvo egypt researching a bioethical question
 
EMPHNET-PHE course: Module03 ethical issues in surveillance, screening and ou...
EMPHNET-PHE course: Module03 ethical issues in surveillance, screening and ou...EMPHNET-PHE course: Module03 ethical issues in surveillance, screening and ou...
EMPHNET-PHE course: Module03 ethical issues in surveillance, screening and ou...
 
The Research Process
The Research ProcessThe Research Process
The Research Process
 
48141 (1).ppt
48141 (1).ppt48141 (1).ppt
48141 (1).ppt
 
Research Techniques.ppt
Research Techniques.pptResearch Techniques.ppt
Research Techniques.ppt
 
Sociological Investigation.ppt
Sociological Investigation.pptSociological Investigation.ppt
Sociological Investigation.ppt
 
17411.ppt
17411.ppt17411.ppt
17411.ppt
 
13b Data analysis and causal inference – 2
13b Data analysis and causal inference – 213b Data analysis and causal inference – 2
13b Data analysis and causal inference – 2
 
Research design
Research designResearch design
Research design
 
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfCCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
 
4 Epidemiological Study Designs 1.pdf
4 Epidemiological Study Designs 1.pdf4 Epidemiological Study Designs 1.pdf
4 Epidemiological Study Designs 1.pdf
 
Study-Designs-in-Epidemiology-2.pdf
Study-Designs-in-Epidemiology-2.pdfStudy-Designs-in-Epidemiology-2.pdf
Study-Designs-in-Epidemiology-2.pdf
 
9. Medical Research.pptx
9. Medical Research.pptx9. Medical Research.pptx
9. Medical Research.pptx
 
Bi ostat for pharmacy.ppt2
Bi ostat for pharmacy.ppt2Bi ostat for pharmacy.ppt2
Bi ostat for pharmacy.ppt2
 

Plus de Institut national du cancer

Plus de Institut national du cancer (13)

Contribution des associations de parents
Contribution des associations de parentsContribution des associations de parents
Contribution des associations de parents
 
L'après-cancer, un sujet de recherche? - Perrine Marec-Bérard
L'après-cancer, un sujet de recherche? - Perrine Marec-BérardL'après-cancer, un sujet de recherche? - Perrine Marec-Bérard
L'après-cancer, un sujet de recherche? - Perrine Marec-Bérard
 
Colloque RI 2014 : Intervention de Ross C. BROWNSON (Washington University in...
Colloque RI 2014 : Intervention de Ross C. BROWNSON (Washington University in...Colloque RI 2014 : Intervention de Ross C. BROWNSON (Washington University in...
Colloque RI 2014 : Intervention de Ross C. BROWNSON (Washington University in...
 
Colloque RI 2014 : Intervention de Zoé VAILLANT (Université Paris Ouest)
Colloque RI 2014 : Intervention de Zoé VAILLANT (Université Paris Ouest)Colloque RI 2014 : Intervention de Zoé VAILLANT (Université Paris Ouest)
Colloque RI 2014 : Intervention de Zoé VAILLANT (Université Paris Ouest)
 
Colloque RI 2014 : Intervention de Michael B. POTTER, MD, (University of Cali...
Colloque RI 2014 : Intervention de Michael B. POTTER, MD, (University of Cali...Colloque RI 2014 : Intervention de Michael B. POTTER, MD, (University of Cali...
Colloque RI 2014 : Intervention de Michael B. POTTER, MD, (University of Cali...
 
Colloque RI 2014 : Intervention de Laurence MOORE (University of Glasgow)
Colloque RI 2014 : Intervention de Laurence MOORE (University of Glasgow)Colloque RI 2014 : Intervention de Laurence MOORE (University of Glasgow)
Colloque RI 2014 : Intervention de Laurence MOORE (University of Glasgow)
 
Colloque RI 2014 : Intervention de Serge BRIANCON (ESP, Faculté de médecine d...
Colloque RI 2014 : Intervention de Serge BRIANCON (ESP, Faculté de médecine d...Colloque RI 2014 : Intervention de Serge BRIANCON (ESP, Faculté de médecine d...
Colloque RI 2014 : Intervention de Serge BRIANCON (ESP, Faculté de médecine d...
 
Colloque RI 2014 : Intervention de Louise POTVIN, PhD, (Institut de recherche...
Colloque RI 2014 : Intervention de Louise POTVIN, PhD, (Institut de recherche...Colloque RI 2014 : Intervention de Louise POTVIN, PhD, (Institut de recherche...
Colloque RI 2014 : Intervention de Louise POTVIN, PhD, (Institut de recherche...
 
Colloque RI 2014 : Intervention de Thierry LANG (Inserm, Université Paul Saba...
Colloque RI 2014 : Intervention de Thierry LANG (Inserm, Université Paul Saba...Colloque RI 2014 : Intervention de Thierry LANG (Inserm, Université Paul Saba...
Colloque RI 2014 : Intervention de Thierry LANG (Inserm, Université Paul Saba...
 
Colloque RI 2014 : Intervention de Pierre LOMBRAIL, PU PH, (SFSP)
Colloque RI 2014 : Intervention de Pierre LOMBRAIL, PU PH, (SFSP)Colloque RI 2014 : Intervention de Pierre LOMBRAIL, PU PH, (SFSP)
Colloque RI 2014 : Intervention de Pierre LOMBRAIL, PU PH, (SFSP)
 
Colloque RI 2014 : Intervention de Gina OGILVIE, MD, (University of British C...
Colloque RI 2014 : Intervention de Gina OGILVIE, MD, (University of British C...Colloque RI 2014 : Intervention de Gina OGILVIE, MD, (University of British C...
Colloque RI 2014 : Intervention de Gina OGILVIE, MD, (University of British C...
 
Colloque RI 2014 : Intervention de Kim RAINE, PhD, (School of public health, ...
Colloque RI 2014 : Intervention de Kim RAINE, PhD, (School of public health, ...Colloque RI 2014 : Intervention de Kim RAINE, PhD, (School of public health, ...
Colloque RI 2014 : Intervention de Kim RAINE, PhD, (School of public health, ...
 
Colloque RI 2014 : Intervention de Sarah VIEHBECK (Institut de la santé publi...
Colloque RI 2014 : Intervention de Sarah VIEHBECK (Institut de la santé publi...Colloque RI 2014 : Intervention de Sarah VIEHBECK (Institut de la santé publi...
Colloque RI 2014 : Intervention de Sarah VIEHBECK (Institut de la santé publi...
 

Dernier

Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls * UPA...
Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls  * UPA...Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls  * UPA...
Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls * UPA...
mahaiklolahd
 

Dernier (20)

Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...
Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...
Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...
 
Call Girls Kolkata Kalikapur 💯Call Us 🔝 8005736733 🔝 💃 Top Class Call Girl Se...
Call Girls Kolkata Kalikapur 💯Call Us 🔝 8005736733 🔝 💃 Top Class Call Girl Se...Call Girls Kolkata Kalikapur 💯Call Us 🔝 8005736733 🔝 💃 Top Class Call Girl Se...
Call Girls Kolkata Kalikapur 💯Call Us 🔝 8005736733 🔝 💃 Top Class Call Girl Se...
 
8980367676 Call Girls In Ahmedabad Escort Service Available 24×7 In Ahmedabad
8980367676 Call Girls In Ahmedabad Escort Service Available 24×7 In Ahmedabad8980367676 Call Girls In Ahmedabad Escort Service Available 24×7 In Ahmedabad
8980367676 Call Girls In Ahmedabad Escort Service Available 24×7 In Ahmedabad
 
Russian Call Girls Service Jaipur {8445551418} ❤️PALLAVI VIP Jaipur Call Gir...
Russian Call Girls Service  Jaipur {8445551418} ❤️PALLAVI VIP Jaipur Call Gir...Russian Call Girls Service  Jaipur {8445551418} ❤️PALLAVI VIP Jaipur Call Gir...
Russian Call Girls Service Jaipur {8445551418} ❤️PALLAVI VIP Jaipur Call Gir...
 
Top Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any Time
Top Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any TimeTop Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any Time
Top Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any Time
 
Trichy Call Girls Book Now 9630942363 Top Class Trichy Escort Service Available
Trichy Call Girls Book Now 9630942363 Top Class Trichy Escort Service AvailableTrichy Call Girls Book Now 9630942363 Top Class Trichy Escort Service Available
Trichy Call Girls Book Now 9630942363 Top Class Trichy Escort Service Available
 
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
 
Call Girls Rishikesh Just Call 9667172968 Top Class Call Girl Service Available
Call Girls Rishikesh Just Call 9667172968 Top Class Call Girl Service AvailableCall Girls Rishikesh Just Call 9667172968 Top Class Call Girl Service Available
Call Girls Rishikesh Just Call 9667172968 Top Class Call Girl Service Available
 
Model Call Girls In Chennai WhatsApp Booking 7427069034 call girl service 24 ...
Model Call Girls In Chennai WhatsApp Booking 7427069034 call girl service 24 ...Model Call Girls In Chennai WhatsApp Booking 7427069034 call girl service 24 ...
Model Call Girls In Chennai WhatsApp Booking 7427069034 call girl service 24 ...
 
Call Girls Hyderabad Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Hyderabad Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Hyderabad Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Hyderabad Just Call 8250077686 Top Class Call Girl Service Available
 
Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...
Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...
Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...
 
Call Girls Service Jaipur {8445551418} ❤️VVIP BHAWNA Call Girl in Jaipur Raja...
Call Girls Service Jaipur {8445551418} ❤️VVIP BHAWNA Call Girl in Jaipur Raja...Call Girls Service Jaipur {8445551418} ❤️VVIP BHAWNA Call Girl in Jaipur Raja...
Call Girls Service Jaipur {8445551418} ❤️VVIP BHAWNA Call Girl in Jaipur Raja...
 
Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls * UPA...
Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls  * UPA...Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls  * UPA...
Call Girl in Indore 8827247818 {LowPrice} ❤️ (ahana) Indore Call Girls * UPA...
 
Andheri East ) Call Girls in Mumbai Phone No 9004268417 Elite Escort Service ...
Andheri East ) Call Girls in Mumbai Phone No 9004268417 Elite Escort Service ...Andheri East ) Call Girls in Mumbai Phone No 9004268417 Elite Escort Service ...
Andheri East ) Call Girls in Mumbai Phone No 9004268417 Elite Escort Service ...
 
Call Girls Raipur Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Raipur Just Call 9630942363 Top Class Call Girl Service AvailableCall Girls Raipur Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Raipur Just Call 9630942363 Top Class Call Girl Service Available
 
💕SONAM KUMAR💕Premium Call Girls Jaipur ↘️9257276172 ↙️One Night Stand With Lo...
💕SONAM KUMAR💕Premium Call Girls Jaipur ↘️9257276172 ↙️One Night Stand With Lo...💕SONAM KUMAR💕Premium Call Girls Jaipur ↘️9257276172 ↙️One Night Stand With Lo...
💕SONAM KUMAR💕Premium Call Girls Jaipur ↘️9257276172 ↙️One Night Stand With Lo...
 
Call Girls Vasai Virar Just Call 9630942363 Top Class Call Girl Service Avail...
Call Girls Vasai Virar Just Call 9630942363 Top Class Call Girl Service Avail...Call Girls Vasai Virar Just Call 9630942363 Top Class Call Girl Service Avail...
Call Girls Vasai Virar Just Call 9630942363 Top Class Call Girl Service Avail...
 
Independent Call Girls In Jaipur { 8445551418 } ✔ ANIKA MEHTA ✔ Get High Prof...
Independent Call Girls In Jaipur { 8445551418 } ✔ ANIKA MEHTA ✔ Get High Prof...Independent Call Girls In Jaipur { 8445551418 } ✔ ANIKA MEHTA ✔ Get High Prof...
Independent Call Girls In Jaipur { 8445551418 } ✔ ANIKA MEHTA ✔ Get High Prof...
 
Call Girls Hosur Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Hosur Just Call 9630942363 Top Class Call Girl Service AvailableCall Girls Hosur Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Hosur Just Call 9630942363 Top Class Call Girl Service Available
 
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
 

Colloque RI 2014 : Intervention de Mark PETTICREW (London School of Hygiene and Tropical Medicine)

  • 1. Evidence-based policy making…what type of evidence do we need? Mark Petticrew Faculty of Public Health and Policy London School of Hygiene and Tropical Medicine Improving health worldwide www.lshtm.ac.uk
  • 2. • We live in a world of evidence-based everything…and everyone wants to be (seen to be) “evidence-based”
  • 3.
  • 6. • The term “evidence” in public health is problematic, by evidence we often mean “trials”, and we wring our hands about the “weak” public health evidence base... • “There isn’t very much evidence, and what there is, isn’t very good”
  • 7. • The term “evidence” is problematic, by evidence we often mean “trials”, and other sorts of evaluations of policies, and we have often wrung our hands about the “weak” public health evidence base... • “There isn’t very much evidence, and what there is, isn’t very good” • So we need to increase the “flow” of evaluations of the health effects of interventions (particularly those outside the health sector)
  • 8. The inverse evidence law • The strongest evidence we have is often about risk factor modification, and we have more, “weaker” evidence about many of the wider social economic and environmental determinants of health (including policies) • E.g. The evidence on modal shift in transport - how to get people to walk and cycle more...
  • 9. Types of intervention • “Health promotion” activities (Education campaigns; free bikes) • Engineering measures (Bicycle infrastructure; traffic restraint) • Financial incentives (voucher/fine to leave car at home) • Providing alternative services (e.g. A new railway station) • Complex urban transport policies
  • 10. Study designs used to evaluate interventions to bring about modal shift (Ogilvie et al., 2007) N (studies) Randomised controlled trial (individual-level) 3 Panel survey 13 Repeated cross-sectional survey (community-level) 17 Retrospective or after-only survey 11 Case study /uncertain (city-level) 20
  • 11. • Does “No trial”=“no evidence”?
  • 12. Three public health interventions for which there is “no good evidence” • There have been 5 RCTs of the health effects of social housing investment. They don’t show major significant effects on health. • Is social housing “ineffective”, and so should be withdrawn? • (– I don’t think so)
  • 13. Two more interventions for which there is no trial evidence (but which surely ‘work’) • Zebra crossings: there are no trials, but there is direct experiential evidence, and excellent theory (“common sense”) that if you walk directly into the traffic you will be knocked down...there is no “equipoise” • Gritting pavements. Not worth asking for “perfect evidence”? However, if the question is about the comparative effectiveness (different “doses” of gritting, or salting vs gritting, or CBA of gritting vs public warnings) then this may be worth evaluating (though may not be ethical)
  • 15. The myth of the single “killer” study • In public health there is rarely one single, killer study which tells us definitively what to do (or stop doing) • Good evidence-informed decisions draw on the wider range of prior evidence (including observational evidence), theory as well as what is know about causal mechanisms; along with judgements about plausibility of effects across a range of outcomes • “Best available evidence” may often be good enough • …particularly given the need to act according to the precautionary principle
  • 16. The need for replication • “Too many social scientists expect single experiments to settle issues once and for all. This may be a mistaken generalization from the history of great crucial experiments in physics and chemistry. In actuality the significant experiments in the physical sciences are replicated thousands of times, not only in deliberate replication efforts, but also as inevitable incidentals in successive experimentation and in utilizations of those many measurement devices (such as the galvanometer) that in their own operation embody the principles of classic experiments. (Campbell, Reforms as Experiments, 1969).
  • 17. • Because we social scientists have less ability to achieve “experimental isolation”, because we have good reason to expect our treatment effects to interact significantly with a wide variety of social factors, many of which we have not yet mapped, we have much greater needs for replication experiments than do the physical sciences….
  • 18. • “Policy outcomes can be monitored with triangulated methods (accumulation of evidence from a variety of sources to gain insight, often combining quantitative and qualitative data)”* *Brownson, Chriqui & Stamakis (2009)
  • 19. All those problems...where are the answers? • The answers do not lie simply in more epidemiology, or more research • But also in understanding the political and other cultures within which evidence is produced, valued, used, misused, or not used at all (in different sectors) • And a greater focus on the decisions that are taken: • “What type and strength of evidence (if any) is needed to support the decision that needs to be taken”
  • 20. • Q: Is, as SV said yesterday, « the best the enemy of the good » in the case of public health evidence? (A: Yes) • We need robust RCTs where these are possible • For addressing the most complex influences on health, we need to also rely on complex sets of epidemiological evidence, including modelling studies, knowledge about causes and mechanisms • We need to be wary of over-emphasising the problems with public health evidence – it ignores the contribution of different types of evidence to decisionmaking • A cautionary tale about « methodological purism »:
  • 21. The 7 CEO’s of Big Tobacco • Testified in turn to Senator Waxman’s hearings (1980-1994): “I believe that tobacco is not addictive” • The tobacco industry developed a range of sophisticated epidemiological and methodological arguments to undermine the public health evidence base on the harms of tobacco • Their “multifactorial causes” argument was developed to argue that epidemiological studies are hopelessly confounded; nothing can be “proved”:
  • 22. “Stressed-out” smokers • “While some scientists have associated cigarette smoking with heart disease, it is certainly clear that a number of other factors including life-style, blood pressure, biochemistry, genetics and in particular, stress, may also be involved” • ‘‘These diseases are also statistically associated with many other variables, such as diet, lifestyle, heredity and stress. . . . But the existence of a statistical association does not mean that smoking causes these diseases.’’ (BAT statement to the Irish Joint Committee on Health and Children in 1998)* *Am J PH Paper on tobacco industry funding of stress: http://researchonline.lshtm.ac.uk/3743/
  • 24. • Ulucanlar et al. (2014)
  • 25. • First, published studies were repeatedly misquoted, distorting the main messages. • Second, ‘mimicked scientific critique’ was used to undermine • evidence; this form of critique insisted on methodological perfection, rejected methodological pluralism, adopted a litigation (not scientific) model*, and was not rigorous. • Third, TTCs engaged in ‘evidential landscaping’, promoting a parallel evidence base to deflect attention from SP and excluding company-held evidence relevant to SP. *Examining and discounting studies piece by piece
  • 26. Example of evidential landscaping • ‘… the real drivers of smoking initiation include factors such as parental influences, risk preferences, peer influences, socioeconomic factors, access and price’
  • 27. • Our natural scientific concern with rigour and internal validity needs to be balanced with the need to integrate a wide range of evidence to feed into policy and other decisions • We need to be aware of how others are interpreting and using the concept of evidence • Developing better public health evidence, is an incremental process
  • 28. No, that last slide was too pessimistic… • A more positive message: • We have public health methods are as robust as those used in the physical sciences – the exact same methods in many cases • RISP methods are reliable, widely accepted, tried and tested (centuries old!) and appropriate for investigating and estimating the effects of policies on health • We need to take every opportunity to reinforce this message